Mérieux Equity Partners
Mérieux Equity Partners, established in 2009 and based in Lyon, France, is a private equity firm focused on venture, growth, and leveraged buyout (LBO) investments within the healthcare and nutrition sectors. The firm targets early-stage and growth capital opportunities in areas such as biotechnology, pharmaceuticals, medtech, and life sciences. Mérieux Equity Partners actively supports entrepreneurs and companies offering innovative products and services by leveraging its extensive expertise and international network. Currently, the firm manages over €600 million in assets under management and has recently introduced a new investment vehicle, MP3, with €350 million allocated for growth and LBO opportunities.
Swixx Biopharma is a company that represents biopharma organizations in Central and Eastern Europe (CEE). Founded in 2014 and registered in Baar, Switzerland, it aims to take over the roles of subsidiaries or business units for multinational biopharma, over-the-counter (OTC), and medical device companies in regions they choose not to enter or have exited. Swixx operates with fully owned affiliates across multiple countries, including Albania, Bulgaria, Hungary, Poland, and Romania, among others. The company specializes in research-driven pharmaceutical and healthcare services, focusing on areas such as rare diseases, oncology-hematology, specialty medications, and self-medication. By leveraging its expertise, Swixx Biopharma provides comprehensive health treatment solutions tailored to the needs of the CEE market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.